Adicet Bio, Inc. (ACET) Two-Stage Excess Return Model - Discounting Cash Flows
Adicet Bio, Inc.
ACET (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Results

Estimated Value -0.449 USD
Book value of equity invested 1.77 USD
Sum of discounted excess returns in Growth Stage -0.629 USD
Terminal stage EPS 0.101 USD
Terminal stage Book Value 2.6 USD
Terminal stage Equity Cost 0.297 USD
Discounted excess return in terminal stage -1.59 USD
Excess Returns in the Terminal Stage -2.73 USD
Terminal Cost of Equity (the discount rate) 11.41%
Terminal year's excess return -0.196 USD
Average historical Return on Equity 3.88%
Average historical Payout Ratio -3.94%
Payout Ratio in stable stage -9.19%
Yield of the U.S. 10 Year Treasury Bond 4.24%

Historical and Forecasted Data

In USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 3.95 2.12 2.12 2.21 2.3 2.4 2.5
Ending Book Value 2.12 1.77 2.21 2.3 2.4 2.5 2.6
EPS -1.33 -1.3 0.082 0.086 0.089 0.093 0.097
Return on Equity -68.82% -62.87% 3.88% 3.88% 3.88% 3.88% 3.88%
Dividend per Share
0.15 -0.004 -0.005 -0.006 -0.008 -0.009
Payout Ratio -5% -11.54% -5% -6.04% -7.09% -8.14% -9.19%
Retained Earnings
-1.45 0.087 0.091 0.096 0.101 0.106
Equity Cost 0.451 0.242 0.242 0.252 0.263 0.274 0.285
Cost of Equity 11.41% 11.41% 11.41% 11.41% 11.41% 11.41% 11.41%
Excess Return -1.78 -1.54 -0.16 -0.166 -0.173 -0.18 -0.188
Discounted Excess Return
-0.143 -0.134 -0.125 -0.117 -0.11

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income -53.18 -117.3 -117.1 -142.7 -67.03 -62 -36.68 -28.14 -9.3 -33.78 -0.001 29
Total Stockholders Equity 59.79 161.4 186.6 170.2 -238.1 -168.3 -106.3 -60.37 104.2 49.69 304.4 254.2
Return on Equity 4.27% -62.87% -68.82% 59.91% 39.82% 58.31% 60.76% -27% -18.71% -11.1% 0% 12.42%
Dividends Paid to Common Shareholders 8.38 13.66
6.96 7.01 5.88
Payout Ratio -4.71% -11.54% -5% -5% -5% -5% -5% -5% -5% -20.63% -5% 20.34%
Shares Outstanding 39 91.07 87.87 43.04 41.08 30.95 7.32 18.56 29.8 26.77 28.05 24.5
Earnings per Share -1.65 -1.3 -1.33 -3.31 -1.63 -2 -5.01 -1.52 -0.31 -1.26 0 1.18
Dividend per Share 0.225 0.15
0.26 0.25 0.24
Dividend Growth Rate 4.08%
4% 4.17% 0%
Book Value 0.492 1.77 2.12 3.95 -5.8 -5.44 -14.53 -3.25 3.5 1.86 10.85 10.38
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us